Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Drug Formulary Review Archives – September 1, 2007

September 1, 2007

View Archives Issues

  • Stand and deliver: Vaccine standing orders program boosts immunizations

    Determined to improve a dropping in-hospital vaccination rate for pneumococcal polysaccharide vaccinations, University of Pittsburgh Medical Center-Presbyterian (UPMC-P) went on the cutting edge nationally to design and implement a pharmacist-run inpatient program that successfully reversed the trend.
  • Unsafe drug orders slipping through in Pennsylvania

    A voluntary assessment of electronic pharmacy systems in Pennsylvania facilities showed the systems are not detecting all unsafe drug orders, Pennsylvania's Patient Safety Authority reports . The authority said all Pennsylvania facilities should test their systems to ensure they are catching potentially harmful medication errors.
  • Know what questions to ask to assess drug interaction

    Researchers at the University of Washington have developed a 10-question format as part of a Drug Interaction Probability Scale (DIPS) to provide a guide to evaluating drug interaction causation in specific patients. (See Drug Utilization Review, May 2007, p. 39) DIPS is intended to be used to assist practitioners in assessing drug interaction-induced adverse outcomes.
  • News Briefs

    Pharmacy groups create pandemic flu guide; Medication database may help in disasters; German hospital tests RFID drug tracking; Pharmacists gain input into Joint Commission revision
  • New FDA Approvals

    The Food and Drug Administration recently announced the following approvals:
  • Drug Criteria & Outcomes: Retapamulin (Altabax™) Formulary Evaluation 

    FDA Approved Indication: Retapamulin: For adults and pediatric patients aged nine months and older for impetigo (up to 100 cm2 of total area in adults or 2% total body surface area in pediatric patients) due to methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes.